These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4174634)

  • 1. Accumulation of chlorpropamide caused by dicoumarol.
    Kristensen M; Hansen JM
    Acta Med Scand; 1968; 183(1-2):83-6. PubMed ID: 4174634
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and biotransformation of chlorpropamide in man.
    Taylor JA
    Clin Pharmacol Ther; 1972; 13(5):710-8. PubMed ID: 5053812
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the metabolic fate of chlorpropamide in man.
    Brotherton PM; Grieveson P; McMartin C
    Clin Pharmacol Ther; 1969; 10(4):505-14. PubMed ID: 5793755
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and biotransformation of chlorpropamide in the rat and dog.
    Taylor JA
    Drug Metab Dispos; 1974; 2(3):221-7. PubMed ID: 4152995
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ovarian hemorrhage in the course of uncontrolled dicumarol therapy].
    Mieszczerski J
    Zentralbl Gynakol; 1965 Jul; 87(29):1005-8. PubMed ID: 4158427
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic behavior of chlorpropamide and sulfadimethoxine in alloxan diabetic rabbits.
    Nishihata T; Yata N; Kamada A
    Chem Pharm Bull (Tokyo); 1978 Nov; 26(11):3353-63. PubMed ID: 729121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents].
    Christensen LK; Kristensen M
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():116-36. PubMed ID: 4190079
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of renal insufficiency on the hypoglycemic action of sulfonylureas. Kinetics of chlorpropamide in a case of nephropathy].
    Pettipierre B; Fabre J
    Schweiz Med Wochenschr; 1972 Apr; 102(16):570-8. PubMed ID: 5019376
    [No Abstract]   [Full Text] [Related]  

  • 9. Gas chromatographic method for determination of tolbutamide and chlorpropamide.
    Sabih K; Sabih K
    J Pharm Sci; 1970 Jun; 59(6):782-4. PubMed ID: 5423077
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics.
    Neuvonen PJ; Kärkkäinen S
    Clin Pharmacol Ther; 1983 Mar; 33(3):386-93. PubMed ID: 6297841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between curry ingredient (karela) and drug (chlorpropamide).
    Aslam M; Stockley IH
    Lancet; 1979 Mar; 1(8116):607. PubMed ID: 85186
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of drug metabolism by chloramphenicol.
    Christensen LK; Skovsted L
    Lancet; 1969 Dec; 2(7635):1397-9. PubMed ID: 4188280
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of chlorpropamide in the treatment of Parkinsonism.
    Ahmed I; Ahmad B; Hussain MF
    Br J Clin Pract; 1968 Jul; 22(7):293-5. PubMed ID: 5659795
    [No Abstract]   [Full Text] [Related]  

  • 14. [On a case of hypoglycemic coma in the course of tolbutamide and dicoumarol therapy].
    Fontana G; Addarii F; Peta G
    G Clin Med; 1968 Sep; 49(9):849-58. PubMed ID: 4180318
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorrhagic complications due to long-term administration of dicoumarol derivatives in coronary artery disease].
    Korolko A
    Pol Tyg Lek; 1973 Oct; 28(43):1680-3. PubMed ID: 4128647
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraocular hemorrhage and blindness associated with systemic anticoagulation.
    Feman SS; Bartlett RE; Roth AM; Foos RY
    JAMA; 1972 Jun; 220(10):1354-5. PubMed ID: 4112318
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability of chlorpropamide.
    Evans M; Glass RC; Mitchard M; Munday BM; Yates R
    Br J Clin Pharmacol; 1979 Jan; 7(1):101-5. PubMed ID: 760732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine pH is important for chlorpropamide elimination.
    Kärkkäinen S; Vapaatalo H; Neuvonen PJ
    Diabetes Care; 1983; 6(3):313. PubMed ID: 6347584
    [No Abstract]   [Full Text] [Related]  

  • 19. The bioavailability in man of marketed brands of chlorpropamide.
    Monro AM; Welling PG
    Eur J Clin Pharmacol; 1974; 7(1):47-9. PubMed ID: 4854667
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlorpropamide and chloramphenicol.
    Hansten PD
    Lancet; 1970 May; 1(7657):1173. PubMed ID: 4192121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.